Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:3/30/2017
Start Date:July 2010
End Date:April 2012

Use our guide to learn which trials are right for you!

Testing Spread and Implementation of Novel MRSA-Reducing Practices

The purpose of this study is to implement strategies for improved efficiency and waste
reduction ("Toyota Lean") and positive deviance, a social behavioral change process,
utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA
infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit
healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery
and action" dialogues to identify and implement care process changes to reduce infection.
Outcomes to be monitored will include incidence of bloodstream infections and MRSA
infections of all types. Data will be assessed at quarterly intervals using interrupted time
series analysis.


Inclusion Criteria: all hemodialysis patients at two outpatient dialysis units

Exclusion Criteria:peritoneal dialysis patients
We found this trial at
1
site
22 Bramhall St
Portland, Maine 04102
(207) 662-0111
Maine Medical Center One of the country's consistently highest rated hospitals is right in your...
?
mi
from
Portland, ME
Click here to add this to my saved trials